Lucid Diagnostics (LUCD) Free Cash Flow (2020 - 2026)
Lucid Diagnostics filings provide 5 years of Free Cash Flow readings, the most recent being -$12.6 million for Q4 2025.
- On a quarterly basis, Free Cash Flow fell 24.74% to -$12.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$46.7 million, a 5.05% decrease, with the full-year FY2025 number at -$46.7 million, down 5.05% from a year prior.
- Free Cash Flow hit -$12.6 million in Q4 2025 for Lucid Diagnostics, down from -$10.9 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$2.2 million in Q3 2021 to a low of -$13.5 million in Q2 2022.
- Median Free Cash Flow over the past 5 years was -$10.1 million (2023), compared with a mean of -$8.8 million.
- The widest YoY moves for Free Cash Flow: up 60.21% in 2022, down 490.02% in 2022.
- Lucid Diagnostics' Free Cash Flow stood at -$10.7 million in 2021, then surged by 60.21% to -$4.3 million in 2022, then tumbled by 138.47% to -$10.2 million in 2023, then increased by 0.24% to -$10.1 million in 2024, then fell by 24.74% to -$12.6 million in 2025.
- The last three reported values for Free Cash Flow were -$12.6 million (Q4 2025), -$10.9 million (Q3 2025), and -$10.6 million (Q2 2025) per Business Quant data.